Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ANTIBODIES, MONOCLONAL, HUMANIZED - THERAPEUTIC USE , . Treffer: 27

2020

Ständer, S; Yosipovitch, G; Legat, FJ; Lacour, JP; Paul, C; Narbutt, J; Bieber, T; Misery, L; Wollenberg, A; Reich, A; Ahmad, F; Piketty, C Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
N Engl J Med. 2020; 382(8):706-716
Web of Science PubMed FullText FullText_MUG

 

2018

Rogatsch, M; Schmid, J; Lax, S; Uranitsch, M; Schmid-Zalaudek, K; Giuffrida, R; Zalaudek, I Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.
Eur J Cancer. 2018; 90:146-148 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2017

Dejaco, C; Brouwer, E; Mason, JC; Buttgereit, F; Matteson, EL; Dasgupta, B Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.
NAT REV RHEUMATOL. 2017; 13(10): 578-592. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kandolf Sekulovic, L; Peris, K; Hauschild, A; Stratigos, A; Grob, JJ; Nathan, P; Dummer, R; Forsea, AM; Hoeller, C; Gogas, H; Demidov, L; Lebbe, C; Blank, C; Olah, J; Bastholt, L; Herceg, D; Neyns, B; Vieira, R; Hansson, J; Rutkowski, P; Krajsova, I; Bylaite-Bucinskiene, M; Zalaudek, I; Maric-Brozic, J; Babovic, N; Banjin, M; Putnik, K; Weinlich, G; Todorovic, V; Kirov, K; Ocvirk, J; Zhukavets, A; Kukushkina, M; De La Cruz Merino, L; Ymeri, A; Risteski, M; Garbe, C More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments.
Eur J Cancer. 2017; 75(4):313-322
Web of Science PubMed FullText FullText_MUG

 

Petrella, TM; Robert, C; Richtig, E; Miller, WH; Masucci, GV; Walpole, E; Lebbe, C; Steven, N; Middleton, MR; Hille, D; Zhou, W; Ibrahim, N; Cebon, J Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
EUR J CANCER. 2017; 86(5): 115-124. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281
Web of Science PubMed FullText FullText_MUG

 

2015

Bykerk, VP; Östör, AJ; Alvaro-Gracia, J; Pavelka, K; Román Ivorra, JA; Graninger, W; Bensen, W; Nurmohamed, MT; Krause, A; Bernasconi, C; Aassi, M; Sibilia, J Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice.
Clin Rheumatol. 2015; 34(3):563-571 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gnant, M; all ABCSG-18 investigators Denosumab and fracture risk in women with breast cancer - Author's reply.
Lancet. 2015; 386(10008): 2057-2058.
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Austrian Breast and Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
LANCET. 2015; 386(9992): 433-443.
Web of Science PubMed FullText FullText_MUG

 

Kreutzer, TC; Wolf, A; Dirisamer, M; Strauss, RW; Foerster, P; Feltgen, N; Pielen, A; Hattenbach, LO; Kampik, A; Priglinger, SG Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial.
Ophthalmologica. 2015; 233(1):8-17 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A; KEYNOTE-006 investigators Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med. 2015; 372(26):2521-2532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Heiduschka, G; Grah, A; Oberndorfer, F; Seemann, R; Kranz, A; Kornek, G; Wrba, F; Thurnher, D; Selzer, E Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab.
Strahlenther Onkol. 2014; 190(9):832-838
Web of Science PubMed FullText FullText_MUG

 

Jacobsen, C; Zemann, W; Obwegeser, JA; Grätz, KW; Metzler, P The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
Oral Maxillofac Surg. 2014; 18(1):31-37
PubMed FullText FullText_MUG

 

Pichler, M; Winter, E; Ress, AL; Bauernhofer, T; Gerger, A; Kiesslich, T; Lax, S; Samonigg, H; Hoefler, G miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor.
J Clin Pathol. 2014; 67(3):198-203
Web of Science PubMed FullText FullText_MUG

 

Roux, C; Hofbauer, LC; Ho, PR; Wark, JD; Zillikens, MC; Fahrleitner-Pammer, A; Hawkins, F; Micaelo, M; Minisola, S; Papaioannou, N; Stone, M; Ferreira, I; Siddhanti, S; Wagman, RB; Brown, JP Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label study.
Bone. 2014; 58(2):48-54 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tarmann, L; Langmann, G; Mayer, C; Weger, M; Haas, A; Wackernagel, W Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.
Acta Ophthalmol. 2014; 92(8):e694-e696 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Krebs, I; Vécsei Marlovits, V; Bodenstorfer, J; Glittenberg, C; Ansari Shahrezaei, S; Ristl, R; Binder, S Comparison of Ranibizumab monotherapy versus combination of Ranibizumab with photodynamic therapy with neovascular age-related macular degeneration.
Acta Ophthalmol. 2013; 91(3):e178-e183 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kump, PK; Högenauer, C; Wenzl, HH; Petritsch, W A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.
J Crohns Colitis. 2013; 7(1):e15-e18 (- Case Report) [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Pansy, J; Fritsch, P; Sovinz, P; Lackner, H; Schwinger, W; Urban, C; Benesch, M Add-on-therapy with bevacizumab in children and adolescents with poor prognosis non-CNS solid tumors.
Anticancer Drugs. 2013; 24(2):198-203
Web of Science PubMed FullText FullText_MUG

 

Resch, B; Michel-Behnke, I Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab.
Curr Opin Cardiol. 2013; 28(2):85-91
Web of Science PubMed FullText FullText_MUG

 

Seidel, G; Werner, C; Weger, M; Steinbrugger, I; Haas, A Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Acta Ophthalmol. 2013; 91(6):e482-e485 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Boltz, A; Ruiâ, M; Jonas, JB; Tao, Y; Rensch, F; Weger, M; Garhöfer, G; Frantal, S; El-Shabrawi, Y; Schmetterer, L Role of Vascular Endothelial Growth Factor Polymorphisms in the Treatment Success in Patients with Wet Age-related Macular Degeneration.
Ophthalmology. 2012; 119(8):1615-1620
Web of Science PubMed FullText FullText_MUG

 

Grunewald, TGP; Greulich, N; Kontny, U; Fruhwald, M; Rutkowski, S; Kordes, U; Scheurlen, W; Schmidt, W; Stachel, D; Metzler, M; Mittler, U; Graf, N; Benesch, M; Burdach, S Targeted Therapeutics in Treatment of Children and Young Adults with Solid Tumors: an Expert Survey and Review of the Literature
Klin Padiatr. 2012; 224(3):124-131
Web of Science PubMed FullText FullText_MUG

 

Manzoni, P; Paes, B; Resch, B; Mejias, A; Ramilo, O; Carbonell-Estrany, X; Bont, L High risk for RSV bronchiolitis in late preterms and selected infants affected by rare disorders: a dilemma of specific prevention.
Early Hum Dev. 2012; 88 Suppl 2(8):S34-S41
Web of Science PubMed FullText FullText_MUG

 

Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Geist, C; Dahlbom, M; Silverman, DH; Satyamurthy, N; Phelps, ME; Chen, W 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab.
J Nucl Med. 2012; 53(1):29-36 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Thonhofer, R; Hiller, M; Just, H; Trummer, M; Siegel, C; Dejaco, C Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
Rheumatol Int. 2011; 31(12): 1653-1656. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum